Ana Marote
0000-0003-0090-9196
28 papers found
Refreshing results…
Treating Parkinson’s Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration
Cerebral Malaria Model Applying Human Brain Organoids
Cerebral Organoids to Study Central Mechanisms of Pain: The Effect of Stem Cell Secretome on Opioid Receptors and Neuroplasticity
Cellular Aging Secretes: a Comparison of Bone-Marrow-Derived and Induced Mesenchymal Stem Cells and Their Secretome Over Long-Term Culture
Enhanced neuronal differentiation by dynamic piezoelectric stimulation
Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response
Fractionating stem cells secretome for Parkinson's disease modeling: Is it the whole better than the sum of its parts?
Compositions for therapy or treatment of Parkinson's disease, methods and uses thereof
Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
Applications of the stem cell secretome in regenerative medicine
Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model
Extremely low frequency magnetic field induces human neuronal differentiation through NMDA receptor activation
Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury
Capacitive technologies for highly controlled and personalized electrical stimulation by implantable biomedical systems
Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
Cell secretome based approaches in Parkinson’s disease regenerative medicine
Electrically polarized PLLA nanofibers as neural tissue engineering scaffolds with improved neuritogenesis
Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene
Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease
Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease
Missing publications? Search for publications with a matching author name.